Pharmacologically, α-MSH is extremely effective in preclinical treatment of local and systemic inflammatory disorders such as sepsis syndrome, acute respiratory distress syndrome, rheumatoid arthritis, inflammatory bowel disease, encephalitis [13,16]. Here, STAMBP is linked to encephalitis.